OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines
Dixita M. Patel, Ruba Mateen, Noor Qaddour, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 335-335
Open Access | Times Cited: 10
Dixita M. Patel, Ruba Mateen, Noor Qaddour, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 335-335
Open Access | Times Cited: 10
Showing 10 citing articles:
Targeting Cancer Stem Cells in Gynecological Malignancies: Emerging Advanced Therapeutic Approaches
Rama Satya Sri Kotipalli, Mani Sharma, Nemala Siva Kumar, et al.
IntechOpen eBooks (2025)
Closed Access
Rama Satya Sri Kotipalli, Mani Sharma, Nemala Siva Kumar, et al.
IntechOpen eBooks (2025)
Closed Access
Decoding oncogenic secrets of regulator of chromosome condensation 1: A breakthrough mechanistic evidence from breast and lung cancer models
Mohamed El‐Tanani, Shakta Mani Satyam, Syed Arman Rabbani, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0319748-e0319748
Open Access
Mohamed El‐Tanani, Shakta Mani Satyam, Syed Arman Rabbani, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0319748-e0319748
Open Access
Strategies to overcome resistance to enfortumab vedotin and pembrolizumab for patients with urothelial carcinoma: harnessing present knowledge for future advances
Albert Jang, Jason R. Brown
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Albert Jang, Jason R. Brown
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
The impact of compression and confinement in tumor growth and progression: emerging concepts in cancer mechanobiology
Allison McKenzie Johnson, Charles Froman-Glover, Akshitkumar M. Mistry, et al.
Frontiers in Materials (2025) Vol. 12
Open Access
Allison McKenzie Johnson, Charles Froman-Glover, Akshitkumar M. Mistry, et al.
Frontiers in Materials (2025) Vol. 12
Open Access
Glycan-based therapeutic approaches for bladder cancer: Overcoming clinical barriers
Rui Freitas, Andreia Peixoto, Lúcio Lara Santos, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189327-189327
Closed Access
Rui Freitas, Andreia Peixoto, Lúcio Lara Santos, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189327-189327
Closed Access
Mechanistic Insights into the Successful Development of Combination Therapy of Enfortumab Vedotin and Pembrolizumab for the Treatment of Locally Advanced or Metastatic Urothelial Cancer
Caroline Taylor, Kamai M. Patterson, Devira Friedman, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3071-3071
Open Access | Times Cited: 1
Caroline Taylor, Kamai M. Patterson, Devira Friedman, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3071-3071
Open Access | Times Cited: 1
Is it possible to get survival benefit in advanced malignant tumors? (data from trials, critical aspects)
A.I. Semenova Semenova
Practical oncology (2024) Vol. 25, Iss. 1, pp. 17-24
Open Access
A.I. Semenova Semenova
Practical oncology (2024) Vol. 25, Iss. 1, pp. 17-24
Open Access
Identification of a circadian-based prognostic signature predicting cancer-associated fibroblasts infiltration and immunotherapy response in bladder cancer
Li Zhou, Jiaming He, Zhiming Hu, et al.
Aging (2024)
Open Access
Li Zhou, Jiaming He, Zhiming Hu, et al.
Aging (2024)
Open Access
Evolving Treatment Landscape of Frontline Therapy for Metastatic Urothelial Carcinoma: Current Insights and Future Perspectives
Whi‐An Kwon, Min-Kyung Lee
Cancers (2024) Vol. 16, Iss. 23, pp. 4078-4078
Open Access
Whi‐An Kwon, Min-Kyung Lee
Cancers (2024) Vol. 16, Iss. 23, pp. 4078-4078
Open Access
FGFR-Altered Urothelial Carcinoma: Resistance Mechanisms and Therapeutic Strategies
David J. Benjamin, Alain C. Mita
Targeted Oncology (2024)
Closed Access
David J. Benjamin, Alain C. Mita
Targeted Oncology (2024)
Closed Access
